Distinct gene expression signatures were observed in the tumors with different receptor profiles, with triple-negative breast cancer expression patterns being more similar to each other than to progesterone- and estrogen-receptor expressing tumors (Fig. 5c). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.